Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Trastuzumab Deruxtecan 5,4, Tumor Biomarker Defined

Protocol-ID: 2652 V1.0 (Mini), TRASDE5.4, Tumor Biomarker Defined

Indication(s)

  • Tumor Biomarker Defined (HER2+)
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 01.07.2024